Medical professionals are increasingly emphasising the vital importance of sustained support for individuals who have used new obesity medications, often referred to as 'weight loss jabs', to manage their weight. Experts warn that without comprehensive, long-term assistance, patients are likely to regain the weight lost once they cease taking the medication, undermining the initial positive effects.
These new drugs, such as Wegovy, work by mimicking a hormone that helps people feel full and regulate blood sugar. While effective for weight reduction during treatment, the underlying lifestyle and behavioural changes necessary for long-term weight management are not automatically embedded. Consequently, once the medication is stopped, individuals frequently revert to previous eating patterns and activity levels, leading to weight regain.
The current framework within the National Health Service (NHS) for patients prescribed these medications often lacks a robust, integrated pathway for post-treatment support. This gap means that while the initial prescription helps patients lose weight, the subsequent phase, crucial for maintaining that loss, is often neglected. This contrasts with the structured behavioural support frequently provided during the clinical trials that demonstrated the drugs' efficacy, which may not be consistently available in real-world clinical practice.
Healthcare professionals are advocating for a shift in perception, stressing that these medications should not be viewed as a standalone 'quick fix'. Instead, they argue that the drugs are a valuable tool to initiate weight loss, but must be complemented by comprehensive programmes focusing on diet, exercise, psychological support, and ongoing behavioural therapy. Such integrated care is essential to equip patients with the skills and habits needed for sustained health improvements.
The broader implications for public health and NHS resources are significant. If patients repeatedly lose and regain weight, it not only impacts their individual health and morale but also places a cyclical burden on healthcare services. Developing and implementing clear guidelines for long-term support post-medication could prove more cost-effective and beneficial in the long run, fostering genuine and lasting health outcomes for those struggling with obesity.
Source: BBC